---
title: "JEI: Approval from Hebei Construction Investment Group for issuing stocks to specific targets"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255945647.md"
description: "On the evening of September 4th, JEI announced that the company received a reply from its controlling shareholder, Hebei Construction Investment Group, agreeing to the plan for the company to issue no more than 231 million shares to no more than 35 specific targets through a bidding process"
datetime: "2025-09-04T11:24:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255945647.md)
  - [en](https://longbridge.com/en/news/255945647.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255945647.md)
generator: "portal-rs"
---

# JEI: Approval from Hebei Construction Investment Group for issuing stocks to specific targets

On the evening of September 4th, JEI announced that the company received a reply from its controlling shareholder, Hebei Construction Investment Group, agreeing to the plan for the company to issue no more than 231 million shares to no more than 35 specific targets through a bidding process

### Related Stocks

- [000600.CN](https://longbridge.com/en/quote/000600.CN.md)

## Related News & Research

- [Exxaro Resources Non-GAAP EPS of R 13.77, revenue of R 22.1B; reaffirms FY 2026 outlook](https://longbridge.com/en/news/296457906.md)
- [Alex Jones gets Sandy Hook family's Texas verdict reduced on appeal](https://longbridge.com/en/news/296643067.md)
- [Bure Equity announces January–June 2026 interim report video release](https://longbridge.com/en/news/296444969.md)
- [JD Sports cuts profit forecast as Régis Shultz turnaround slows](https://longbridge.com/en/news/296443354.md)
- [Tvardi Therapeutics: TTI-109 targets STAT3 to address unmet needs in UC with selective immune modulation and safety](https://longbridge.com/en/news/296374826.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**